We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Can Optum Offset UnitedHealth's Health Benefits Growth Woes?
Read MoreHide Full Article
Key Takeaways
UnitedHealth leans on Optum to offset pressures in its health benefits business.
Optum's revenue growth outpaced UnitedHealthcare from 2022 to 2024.
Optum contributed over half of UnitedHealth's total operating income last year.
Yes, UnitedHealth Group Incorporated (UNH - Free Report) is increasingly relying on its Optum business to drive growth and offset challenges in the health benefits segment, UnitedHealthcare. Optum has become the company’s primary growth engine, delivering stronger margins and faster revenue growth compared with the insurance unit, which remains pressured by rising medical costs, particularly in Medicare Advantage.
The business operates across three key areas: Optum Health (care delivery and physician groups), Optum Insight (data analytics and tech solutions) and Optum Rx (pharmacy benefit management). These are less vulnerable to the cost fluctuations that weigh on insurance operations.
From 2022 to 2024, Optum’s revenues grew 17.5%, 24% and 11.6%, respectively, consistently outpacing UnitedHealthcare’s 12%, 12.7% and 6% growth over the same period, respectively. UNH continues to invest heavily in expanding Optum Health’s clinics and physician groups to build a more integrated, recurring care model and reduce reliance on the insurance segment, which faces regulatory and cost pressures.
Optum Insight’s advanced data capabilities give UNH a competitive edge in risk prediction and care management across both business arms. However, the Change Healthcare cyberattack in early 2024 exposed vulnerabilities and led to financial and reputational setbacks. Still, analysts expect Optum to remain UNH’s key profit driver, as it accounted for more than half of total operating income in 2024.
Overall, UnitedHealth’s strategic focus on Optum is a clear move to counterbalance the struggles in the health benefits business and maintain long-term earnings growth, especially as it withdraws from unprofitable international markets like South America.
How Are Humana & Elevance Health Faring Compared With UNH?
Humana Inc. (HUM - Free Report) has seen relatively weaker profits, declining about 1% over the past five years against UnitedHealth's 13% growth. Its adjusted net margins, 4.4% in the first quarter of 2025, trail behind UNH’s 6%. Humana’s benefits expenses rose 13.9% year over year in 2024 and 5.6% in the first quarter of 2025.
Elevance Health, Inc.'s (ELV - Free Report) profits grew 11.3% over the past five years, putting it well above Humana but below UNH. Its adjusted net margin was 5.6% in the first quarter of 2025. Elevance Health’s benefits expenses grew 2.6% in 2024 and 15.6% in the first quarter of 2025.
UnitedHealth’s Price Performance, Valuation and Estimates
Shares of UNH have lost 38.1% in the year-to-date period compared with the industry’s decline of 27.6%.
Image Source: Zacks Investment Research
From a valuation standpoint, UnitedHealth trades at a forward price-to-earnings ratio of 13.18, up from the industry average of 11.95. UNH carries a Value Score of B.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for UnitedHealth’s 2025 earnings is pegged at $22.28 per share, implying a 19.5% drop from the year-ago period.
Image Source: Zacks Investment Research
The stock currently carries a Zacks Rank #5 (Strong Sell).
Image: Bigstock
Can Optum Offset UnitedHealth's Health Benefits Growth Woes?
Key Takeaways
Yes, UnitedHealth Group Incorporated (UNH - Free Report) is increasingly relying on its Optum business to drive growth and offset challenges in the health benefits segment, UnitedHealthcare. Optum has become the company’s primary growth engine, delivering stronger margins and faster revenue growth compared with the insurance unit, which remains pressured by rising medical costs, particularly in Medicare Advantage.
The business operates across three key areas: Optum Health (care delivery and physician groups), Optum Insight (data analytics and tech solutions) and Optum Rx (pharmacy benefit management). These are less vulnerable to the cost fluctuations that weigh on insurance operations.
From 2022 to 2024, Optum’s revenues grew 17.5%, 24% and 11.6%, respectively, consistently outpacing UnitedHealthcare’s 12%, 12.7% and 6% growth over the same period, respectively. UNH continues to invest heavily in expanding Optum Health’s clinics and physician groups to build a more integrated, recurring care model and reduce reliance on the insurance segment, which faces regulatory and cost pressures.
Optum Insight’s advanced data capabilities give UNH a competitive edge in risk prediction and care management across both business arms. However, the Change Healthcare cyberattack in early 2024 exposed vulnerabilities and led to financial and reputational setbacks. Still, analysts expect Optum to remain UNH’s key profit driver, as it accounted for more than half of total operating income in 2024.
Overall, UnitedHealth’s strategic focus on Optum is a clear move to counterbalance the struggles in the health benefits business and maintain long-term earnings growth, especially as it withdraws from unprofitable international markets like South America.
How Are Humana & Elevance Health Faring Compared With UNH?
Humana Inc. (HUM - Free Report) has seen relatively weaker profits, declining about 1% over the past five years against UnitedHealth's 13% growth. Its adjusted net margins, 4.4% in the first quarter of 2025, trail behind UNH’s 6%. Humana’s benefits expenses rose 13.9% year over year in 2024 and 5.6% in the first quarter of 2025.
Elevance Health, Inc.'s (ELV - Free Report) profits grew 11.3% over the past five years, putting it well above Humana but below UNH. Its adjusted net margin was 5.6% in the first quarter of 2025. Elevance Health’s benefits expenses grew 2.6% in 2024 and 15.6% in the first quarter of 2025.
UnitedHealth’s Price Performance, Valuation and Estimates
Shares of UNH have lost 38.1% in the year-to-date period compared with the industry’s decline of 27.6%.
From a valuation standpoint, UnitedHealth trades at a forward price-to-earnings ratio of 13.18, up from the industry average of 11.95. UNH carries a Value Score of B.
The Zacks Consensus Estimate for UnitedHealth’s 2025 earnings is pegged at $22.28 per share, implying a 19.5% drop from the year-ago period.
The stock currently carries a Zacks Rank #5 (Strong Sell).
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.